Valproate blocks high-dose methamphetamine-induced behavioral cross-sensitization to locomotion-inducing effect of dizocilpine (MK-801), but not methamphetamine

Psychopharmacology

Volumn 186, Issue 4, 2006, Pages 525-533

  Ito, K ^a   Abekawa, T ^a   Koyama, T ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cross sensitization; Dizocilpine (MK 801); Glutamate; Methamphetamine; Nucleus accumbens; Valproate

Indexed keywords

DIZOCILPINE; GLUTAMIC ACID; METHAMPHETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; VALPROIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CROSS REACTION; DRUG EFFECT; DRUG MEGADOSE; DRUG WITHDRAWAL; INFRARED RADIATION; LOCOMOTION; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; LOCOMOTION; MALE; METHAMPHETAMINE; MICRODIALYSIS; NEURONAL PLASTICITY; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; TIME FACTORS; VALPROIC ACID;

EID: 33744957413     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-006-0357-8     Document Type: Article

References (47)

1. Abekawa T, Ohmori T, Koyama T (1995) Effects of nitric oxide (NO) synthesis inhibition on the development supersensitivity to stereotypy and locomotion stimulating effects of methamphetamine. Brain Res 679:200-204
2. Abekawa T, Honda M, Ito K, Inoue T, Koyama T (2002a) Effect of MS-153 on the development of behavioral sensitization to locomotion- and ataxia-inducing effects of phencyclidine. Psychopharmacology 160:122-131
3. Abekawa T, Honda M, Ito K, Inoue T, Koyama T (2002b) Effect of MS-153 on the development of behavioral sensitization to stereotypy-inducing effect of phencyclidine. Brain Res 926:176-180
4. Agmo A, Belzung C, Giordano M (1996) Interactions between dopamine and GABA in the control of ambulatory activity. J Neural Transm 103:925-934
5. Bakshi VP, Swerdlow NR, Geyer MA (1994) Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther 271:787-794
6. Beggs CS, Pearce BR, Fowler LJ, Whitton PS (1992) Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine, and their metabolites in the rat brain: an in vivo microdialysis study. J Neurochem 59:1702-1708
7. Berendse HW, Galis-de Graaf Y, Groenewegen HJ (1992) Topographical organization and relationship with ventral compartments of prefrontal corticostriatal projections in the rat. J Comp Neurol 316:314-347
8. Chen G, Manji HK, Hawver DB, Wright CB, Potter WZ (1994) Chronic sodium valproate selectively decreases protein kinase C alpha and epsilon in vitro. J Neurochem 63:2361-2364
9. Corbett R, Camacho F, Woods AT (1995) Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors. Psychopharmacology 120:67-74
10. Depoortere R, Perrault G, Sanger DJ (1999) Prepulse inhibition of the startle reflex in rats: effects of compounds acting at various sites of the NMDA receptor complex. Behav Pharmacol 10:51-62
11. Eckermann K, Beasley A, Yang P, Gaytan O, Swann A, Dafny N (2001) Methylphenidate sensitization is modulated by valproate. Life Sci 69:47-57
12. Fang YR, Abekawa T, Li XB, Inoue T, Koyama T (2005) Effect of the protein kinase C inhibitor, staurosporine on the high dose of methamphetamine-induced behavioral sensitization to dizocilpine (MK-801). Psychopharmacology 180:100-106
13. Gleason SD, Shannon HE (1997) Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice. Psychopharmacology 129:79-84
14. Ito K, Ohmori T, Abekawa T, Koyama T (1997) Clonazepam prevents the development of sensitization to methamphetamine. Pharmacol Biochem Behav 58:875-879
15. Ito K, Ohmori T, Abekawa T, Koyama T (2000) The role of benzodiazepine receptors in the acquisition and expression of behavioral sensitization to methamphetamine. Pharmacol Biochem Behav 65:705-710
16. Ito K, Abekawa T, Koyama T (2004) Valproic acid blocked a high dose of methamphetamine-induced behavioral sensitization to locomotion-inducing effect of MK-801, but not methamphetamine (Abstract, program no. 951.15). 34th annual meeting, Society for Neuroscience, San Diego, USA, October 23-27, 2004
17. Kalivas PW, Stewart J (1991) Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev 16:223-244
18. Kalivas PW, Sorg BA, Hooks MS (1993) The pharmacology and neural circuitry of sensitization to psychostimulants. Behav Pharmacol 4:315-334
19. Kitanaka N, Kitanaka J, Takemura M (2003) Behavioral sensitization and alteration in monoamine metabolism in mice after single verses repeated methamphetamine administration. Eur J Pharmacol 474:63-70
20. Krupp JJ, Vissel B, Thomas CG, Heinemann SF, Westbrook GL (2002) Calcineurin acts via the C terminus of NR2A to modulate desensitization of NMDA receptors. Neuropharmacology 42:593-602
21. Lee GY, Brown LM, Teyler TJ (1996) The effects of anticonvulsant drugs on long-term potentiation (LTP) in the rat hippocampus. Brain Res Bull 39:39-42
22. Li Y, Wolf ME (1999) Can the 'state-dependency' hypothesis explain prevention of amphetamine sensitization in rats by NMDA receptor antagonists? Psychopharmacol 141:351-361
23. Lindekens H, Smolders I, Khan GM, Bialer M, Ebinger G, Michotte Y (2000) In vivo study of the effect of valpromide and in the pilocarpine rat model of focal epilepsy. Pharma Res 17:1408-1413
24. Lindroth P, Mopper K (1979) High performance liquid chromatographic determination of subpicomole amounts of amino acid by precolumn fluorescence derivatization with o-phthaldialdehyde. Anal Chem 51:1667-1674
25. Loscher W (1999) Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action. Prog Neurobiol 58:31-59
26. Lu W, Monteggia LM, Wolf ME (1999) Withdrawal from repeated amphetamine administration reduces NMDAR1 expression in the rat substantia nigra, nucleus accumbens and medial prefrontal cortex. Eur J Neurosci 11:3167-3177
27. Nahum-Levy R, Lipinski D, Shavit S, Benveniste M (2001) Desensitization of NMDA receptor channels is modulated by glutamate agonists. Biophysical J 80:2152-2166
28. Ohmori T, Abekawa T, Muraki A, Koyama T (1994) Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine. Pharmacol Biochem Behav 48:587-591
29. Ohmori T, Abekawa T, Koyama T (1995a) Scopolamine prevents the development of sensitization to methamphetamine. Life Sci 56:1223-1229
30. Ohmori T, Abekawa T, Koyama T (1995b) Scopolamine prevents augmentation of stereotypy induced by chronic methamphetamine treatment. Psychopharmacol 121:158-163
31. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic, Sydney
32. Pierce RC, Kalivas PW (1997) A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 25:192-216
33. Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Brain Res Rev 11:157-198
34. Sato M, Chen CC, Akiyama K, Otsuki S (1983) Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biol Psychiatry 18:429-440
35. Takahata R, Moghaddam B (2003) Activation of glutamate neurotransmission in the prefrontal cortex sustains the motoric and dopaminergic effects of phencyclidine. Neuropsychopharmacology 28:1117-1124
36. Vanderschuren LJ, Kalivas PW (2000) Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) 151:99-120
37. Vezina P (2004) Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs. Neurosci Biobehav Rev 27:827-839
38. Volkow ND, Ding YS, Fowler JS, Wang GJ, Logan J, Gatley JS, Dewey S, Ashby C, Liebermann J, Hitzemann R, Wolf AP (1995) Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry 52:456-463
39. Vriend JP, Alexiuk NA (1996) Effects of valproate on amino acid and monoamine concentration in striatum of audiogenic seizure-prone Balb/c mice. Mol Chem Neuropathol 27:307-324
40. White FJ, Kalivas PW (1998) Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend 51:141-153
41. Wolf ME, Khansa MR (1991) Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res 562:164-168
42. Xue CJ, Ng JP, Li Y, Wolf ME (1996) Acute and repeated systemic amphetamine administration: effects on extracellular glutamate, aspartate, and serine levels in rat ventral tegmental area and nucleus accumbens. J Neurochem 67:352-363
43. Yamamoto H, Kitamura N, Lin XH, Ikeuchi Y, Hashimoto T, Shirakawa O, Maeda K (1999) Differential changes in glutamatergic transmission via N-methyl-D-aspartate receptors in the hippocampus and striatum of rats behaviorally sensitized to methamphetamine. Int J Neuropsychopharmacol 2:155-163
44. Yang PB, Beasley A, Eckermann K, Swann AC, Dafny N (2000) Valproate prevents the induction of sensitization to methylphenidate (ritalin) in rats. Brain Res 887:276-284
45. Yang PB, Swann AC, Dafny N (2002) Valproate prevents the induction and the expression of MK-801 sensitization. Brain Res 954:151-159
46. Zhang MM, Xiao C, Yu K, Ruan DY (2003) Effects of sodium valproate on synaptic plasticity in the CA1 region of rat hippocampus. Food Chem Toxicol 41:1617-1623
47. 2+ concentration mediated by N-methyl-D-aspartate receptor in PO/AH neurons of anoxic SD rats. Di yi jun yi da xue bao 24:461-463, 466